Vicapsys Life Sciences Stock Probability of Future Pink Sheet Price Finishing Under 2.75

VICP Stock  USD 7.00  0.00  0.00%   
Vicapsys Life's future price is the expected price of Vicapsys Life instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vicapsys Life Sciences performance during a given time horizon utilizing its historical volatility. Check out Vicapsys Life Backtesting, Vicapsys Life Valuation, Vicapsys Life Correlation, Vicapsys Life Hype Analysis, Vicapsys Life Volatility, Vicapsys Life History as well as Vicapsys Life Performance.
  
Please specify Vicapsys Life's target price for which you would like Vicapsys Life odds to be computed.

Vicapsys Life Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vicapsys Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vicapsys Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vicapsys Life generated a negative expected return over the last 90 days
Vicapsys Life has a very high chance of going through financial distress in the upcoming years
Vicapsys Life has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vicapsys Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vicapsys Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vicapsys Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vicapsys to invest in growth at high rates of return. When we think about Vicapsys Life's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (765.84 K) with profit before overhead, payroll, taxes, and interest of 0.
Vicapsys Life Sciences currently holds about 17.29 K in cash with (262.9 K) of positive cash flow from operations.
Roughly 46.0% of the company outstanding shares are owned by insiders

Vicapsys Life Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vicapsys Pink Sheet often depends not only on the future outlook of the current and potential Vicapsys Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vicapsys Life's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding17.5 M
Cash And Short Term Investments1269.00
Shares Float13 M

Vicapsys Life Technical Analysis

Vicapsys Life's future price can be derived by breaking down and analyzing its technical indicators over time. Vicapsys Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vicapsys Life Sciences. In general, you should focus on analyzing Vicapsys Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Vicapsys Life Predictive Forecast Models

Vicapsys Life's time-series forecasting models is one of many Vicapsys Life's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vicapsys Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Vicapsys Life Sciences

Checking the ongoing alerts about Vicapsys Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vicapsys Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vicapsys Life generated a negative expected return over the last 90 days
Vicapsys Life has a very high chance of going through financial distress in the upcoming years
Vicapsys Life has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vicapsys Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vicapsys Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vicapsys Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vicapsys to invest in growth at high rates of return. When we think about Vicapsys Life's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (765.84 K) with profit before overhead, payroll, taxes, and interest of 0.
Vicapsys Life Sciences currently holds about 17.29 K in cash with (262.9 K) of positive cash flow from operations.
Roughly 46.0% of the company outstanding shares are owned by insiders

Additional Tools for Vicapsys Pink Sheet Analysis

When running Vicapsys Life's price analysis, check to measure Vicapsys Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicapsys Life is operating at the current time. Most of Vicapsys Life's value examination focuses on studying past and present price action to predict the probability of Vicapsys Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicapsys Life's price. Additionally, you may evaluate how the addition of Vicapsys Life to your portfolios can decrease your overall portfolio volatility.